ProShares - UltraShort Nasdaq Biotechnology (BIS) |
| 16.7959 -0.068 (-0.4%) 06-12 16:00 |
| Open: | 16.77 |
| High: | 16.93 |
| Low: | 16.53 |
| Volume: | 4,228 |
| Market Cap: | 2(M) |
| PE Ratio: | 0 |
| Exchange: | NASDAQ Global Market |
| Industry: | Asset Management - Leveraged |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 18.74 |
| Resistance 1: | 17.85 |
| Pivot price: | 17.21 |
| Support 1: | 16.42 |
| Support 2: | 13.66 |
| 52w High: | 36.8 |
| 52w Low: | 15.9 |
The ProShares UltraShort Nasdaq Biotechnology fund is engineered to achieve daily returns that are precisely two times the inverse (-2x) of the Nasdaq Biotechnology Index's daily performance. This objective is measured before accounting for any associated fees and operational expenses.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Wed, 14 May 2025
Top Performing Leveraged/Inverse ETFs: 05/11/2025 - ETF Database
Tue, 19 Nov 2024
Top Performing Leveraged/Inverse ETFs: 11/17/2024 - ETF Trends
Wed, 17 Apr 2024
The 5 Best Healthcare ETFs of 2023 - ETF.com
Mon, 05 Dec 2022
3 ETFs in “Oversold” Territory to Start the Week - ETF Trends
Tue, 25 Jan 2022
Cap-Weighting Critical When Indexing Biotech - ETF Database
Wed, 05 Jan 2022
2021 Year in Review: Swelling the Ranks of the Nasdaq Biotechnology Index™ - Nasdaq
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
